Literature DB >> 12717123

Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action.

Bertrand Debaene1, Benoît Plaud, Marie-Pierre Dilly, François Donati.   

Abstract

BACKGROUND: Residual neuromuscular blockade remains a problem even after short surgical procedures. The train-of-four (TOF) ratio at the adductor pollicis required to avoid residual paralysis is now considered to be at least 0.9. The incidence of residual paralysis using this new threshold is not known, especially after a single intubating dose of intermediate-duration nondepolarizing relaxant. Therefore, the aim of the study was to determine the incidence of residual paralysis in the postanesthesia care unit after a single intubating dose of twice the ED(95) of a nondepolarizing muscle relaxant with an intermediate duration of action.
METHODS: Five hundred twenty-six patients were enrolled. They received a single dose of vecuronium, rocuronium, or atracurium to facilitate tracheal intubation and received no more relaxant thereafter. Neuromuscular blockade was not reversed at the end of the procedure. On arrival in the postanesthesia care unit, the TOF ratio was measured at the adductor pollicis, using acceleromyography. Head lift, tongue depressor test, and manual assessment of TOF and DBS fade were also performed. The time delay between the injection of muscle relaxant and quantitative measurement of neuromuscular blockade was calculated from computerized anesthetic records.
RESULTS: The TOF ratios less than 0.7 and 0.9 were observed in 16% and 45% of the patients, respectively. Two hundred thirty-nine patients were tested 2 h or more after the administration of the muscle relaxant. Ten percent of these patients had a TOF ratio less than 0.7, and 37% had a TOF ratio less than 0.9. Clinical tests (head lift and tongue depressor) and manual assessment of fade showed a poor sensitivity (11-14%) to detect residual blockade (TOF < 0.9).
CONCLUSION: After a single dose of intermediate-duration muscle relaxant and no reversal, residual paralysis is common, even more than 2 h after the administration of muscle relaxant. Quantitative measurement of neuromuscular transmission is the only recommended method to diagnose residual block.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717123     DOI: 10.1097/00000542-200305000-00004

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  66 in total

1.  Retrospective analysis of spontaneous recovery from neuromuscular blockade produced by empirical use of rocuronium.

Authors:  Hiroto Yamamoto; Tokujiro Uchida; Yudai Yamamoto; Yusuke Ito; Koshi Makita
Journal:  J Anesth       Date:  2011-09-21       Impact factor: 2.078

2.  Effective method of continuous rocuronium administration based on effect-site concentrations using a pharmacokinetic/pharmacodynamic model during propofol-remifentanil anesthesia.

Authors:  Takahiro Moriyama; Akira Matsunaga; Osamu Nagata; Kei Enohata; Tomomi Kamikawaji; Erika Uchino; Yuichi Kanmura
Journal:  J Anesth       Date:  2015-03-01       Impact factor: 2.078

Review 3.  [Residual neuromuscular blockades. Clinical consequences, frequency and avoidance strategies].

Authors:  T Fuchs-Buder; M Eikermann
Journal:  Anaesthesist       Date:  2006-01       Impact factor: 1.041

4.  Laparoscopic partial nephrectomy in a patient on simvastatin : Delayed recovery from neuromuscular blockade.

Authors:  E E Abd El-Hakeem; A M Kaki; S A Almazlom; A J Alsayyad
Journal:  Anaesthesist       Date:  2017-03-06       Impact factor: 1.041

5.  Feasibility of intraoperative neuromonitoring during thyroid surgery after administration of nondepolarizing neuromuscular blocking agents.

Authors:  Koung-Shing Chu; Sheng-Hua Wu; I-Cheng Lu; Cheng-Jing Tsai; Che-Wei Wu; Wen-Rei Kuo; Ka-Wo Lee; Feng-Yu Chiang
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

6.  Computerized recording of neuromuscular monitoring and the risk of residual paralysis at the time of extubation.

Authors:  Cyrus Motamed; Jean-Louis Bourgain
Journal:  J Clin Monit Comput       Date:  2008-08-07       Impact factor: 2.502

Review 7.  Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease.

Authors:  Michiaki Yamakage; Sohshi Iwasaki; Akiyoshi Namiki
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

Review 8.  ERCP: the unresolved question of endotracheal intubation.

Authors:  Basavana Goudra; Preet Mohinder Singh
Journal:  Dig Dis Sci       Date:  2013-11-13       Impact factor: 3.199

Review 9.  Epidural anesthesia and pulmonary function.

Authors:  Harald Groeben
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

Review 10.  Sugammadex: a review of its use in anaesthetic practice.

Authors:  Lily P H Yang; Susan J Keam
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.